
- /
- Supported exchanges
- / US
- / XBIT.NASDAQ
XBiotech Inc (XBIT NASDAQ) stock market data APIs
XBiotech Inc Financial Data Overview
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes true human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get XBiotech Inc data using free add-ons & libraries
Get XBiotech Inc Fundamental Data
XBiotech Inc Fundamental data includes:
- Net Revenue: 300 K
- EBITDA: -43 413 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-08
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
XBiotech Inc News

3 Promising Penny Stocks With Market Caps Above $90M
As the U.S. stock market navigates a landscape shaped by trade talks and economic data, investors are keenly watching for opportunities amid the shifting dynamics. Penny stocks, a term rooted in past ...


XBiotech to Begin Constructing New R&D Facility on its 48-acre Campus
XBiotech Inc. XBiotech Architectural Rendition of XBiotech’s Planned R&D Facility XBiotech Architectural Rendition of XBiotech’s Planned R&D Facility AUSTIN, Texas, Jan. 04, 2024 (GLOBE NEWSWIR...

Companies Like XBiotech (NASDAQ:XBIT) Are In A Position To Invest In Growth
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining exploration companies often lose money for years before finding success with a new trea...

Le Dr Alan Kivitz prend la tête du programme Natrunix, conduit par XBiotech dans le traitement de la polyarthrite rhumatoïde
AUSTIN, État du Texas, 15 nov. 2023 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ : XBIT) annonce ce jour la nomination d’Alan Kivitz, M.D. au titre d’Investigateur principal et Président de la commis...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.